HTML from...
URL: https://open.canada.ca/data/en/dataset/7495720d-ee05-4faa-89d4-7211267848a1
In 2016, Health Canada reviewed the risk of gadolinium build-up in the brain and potential neurological side effects in light of published studies showing that gadolinium may accumulate in the brain when GBCAs are given repeatedly. The neurological effects of these build-ups are not known.
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | January 16, 2026 |
| Metadata last updated | January 16, 2026 |
| Created | January 16, 2026 |
| Format | HTML |
| License | License not specified |
| Datastore active | False |
| Has views | False |
| Id | 999efbb7-9162-4726-8aec-f636737e4014 |
| Package id | c32b21e4-1d0e-457a-be31-4b44844416c3 |
| Position | 0 |
| State | active |